AG

Arvind Gupta

Partner at Mayfield

San Francisco, California

Overview 

Arvind Gupta is a Partner at Mayfield Fund and the Founder of IndieBio, with a strong background in investing in startups across various sectors such as ClimateTech, BioTech, and Web3/Crypto. He has invested in notable companies like Windfall Bio and Prellis Biologics, showcasing his expertise in identifying and supporting innovative ventures. Arvind Gupta's career highlights include founding IndieBio, a leading biotech accelerator, and his role as a Partner at Mayfield Fund, where he has made impactful investments in companies like Geltor and Stämm Biotech.

Work Experience 

  • Partner

    2020 - Current

Mayfield is an early-stage VC firm investing in enterprise, deeptech, and human and planetary health companies.

  • Founder

    2013

  • Venture Advisor at IndieBio

    2020

  • Board Member

    2017 - 2021

  • Board Member

    2019 - 2020

New Culture is a food and beverage company that focuses on revolutionizing how cheese is made.

Raised $28,500,000.00 from CJ CheilJedang Corp..

  • Board Member

    2018 - 2020

One Platform, Many Proteins

Raised $114,250,000.00 from IndieBio, SOSV and Beyond Impact.

  • Board Member

    2016 - 2020

SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.

Raised $11,575,000.00 from Bristol-Myers Squibb.

  • Board Member

    2014 - 2020

  • General Partner, Founder IndieBio

    2013 - 2020

SOSV is a deep tech venture firm that invests from a startup's inception and operates the HAX and IndieBio programs.

  • Co-Founder

    2011 - 2015

  • Design Director - Product Design and Strategy

    2011 - 2013

  • Senior Portfolio Lead for IDEO Asia, IDEO Bay Area

    2008 - 2011

  • Project Leader

    2005 - 2008

  • Senior Industrial Designer

    2003 - 2005

Articles About Arvind

Relevant Websites